Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PRG2,Bone marrow proteoglycan,Inverse variance weighted,36,1.21 [1.12-1.31],1.14647586014242e-06,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,MMP12,Macrophage metalloelastase,Inverse variance weighted,36,1.16 [1.09-1.23],1.54176123098567e-06,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,36,1.2 [1.1-1.3],2.25914912550702e-05,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IL32,Interleukin-32,Inverse variance weighted,36,1.12 [1.06-1.18],2.93619561319599e-05,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,36,1.14 [1.07-1.21],3.35269995364912e-05,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CCL17,C-C motif chemokine 17,Inverse variance weighted,36,1.18 [1.09-1.28],3.83178875775299e-05,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,36,1.14 [1.07-1.21],5.68161660559467e-05,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,36,1.12 [1.06-1.19],7.3887872057288e-05,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,36,1.13 [1.06-1.21],0.000136356095465992,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SLAMF7,SLAM family member 7,Inverse variance weighted,36,1.13 [1.06-1.2],0.000139246537895761,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,36,1.13 [1.06-1.21],0.000148070581739086,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,36,1.13 [1.06-1.2],0.000153644104760896,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,36,1.11 [1.05-1.18],0.00015909987870633,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,36,1.13 [1.06-1.21],0.000180180941050986,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CSTB,Cystatin-B,Inverse variance weighted,36,1.09 [1.04-1.14],0.000255933743454723,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,NECTIN2,Nectin-2,Inverse variance weighted,36,1.11 [1.05-1.18],0.000261304404850096,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,36,1.13 [1.05-1.21],0.000496174218992058,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,36,1.12 [1.05-1.2],0.000516133566535028,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,36,1.11 [1.05-1.18],0.000661567839992365,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,OCLN,Occludin,Inverse variance weighted,36,1.09 [1.04-1.15],0.000710752828065459,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,36,1.11 [1.04-1.18],0.000898230105343149,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,NECTIN4,Nectin-4,Inverse variance weighted,36,1.11 [1.04-1.18],0.000909282679603585,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,B2M,Beta-2-microglobulin,Inverse variance weighted,36,1.12 [1.04-1.19],0.00105352602200119,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,36,1.11 [1.04-1.18],0.00113422908420291,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,36,1.08 [1.03-1.14],0.00130741338024329,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TFF3,Trefoil factor 3,Inverse variance weighted,36,1.09 [1.04-1.16],0.00140900703202412,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNC,Tenascin,Inverse variance weighted,36,1.08 [1.03-1.14],0.00142089331011361,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,36,1.12 [1.04-1.19],0.00148988791780834,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IL19,Interleukin-19,Inverse variance weighted,36,1.13 [1.05-1.21],0.00164570490164403,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TGFA,Protransforming growth factor alpha,Inverse variance weighted,36,1.1 [1.04-1.17],0.00171265126126705,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD83,CD83 antigen,Inverse variance weighted,36,1.11 [1.04-1.19],0.00194322210280724,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,36,1.09 [1.03-1.16],0.00245997671575789,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,36,1.1 [1.03-1.17],0.00258911182458884,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,36,1.1 [1.03-1.17],0.00263164060222449,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,36,1.1 [1.03-1.17],0.00268552309094044,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,36,1.08 [1.03-1.13],0.00279663263519858,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,36,1.12 [1.04-1.21],0.00353508455253881,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,36,1.1 [1.03-1.17],0.00353700643908846,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,DSC2,Desmocollin-2,Inverse variance weighted,36,1.09 [1.03-1.16],0.00360987210732062,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,36,1.08 [1.03-1.14],0.0036507883840753,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,GPR15L,Protein GPR15L,Inverse variance weighted,36,1.1 [1.03-1.16],0.00384012494915985,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,36,1.11 [1.03-1.19],0.00391839788232434,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,EFNA4,Ephrin-A4,Inverse variance weighted,36,1.12 [1.04-1.2],0.00393909603942234,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ADM,Pro-adrenomedullin,Inverse variance weighted,36,1.07 [1.02-1.12],0.00430317841237667,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CST3,Cystatin-C,Inverse variance weighted,36,1.09 [1.03-1.16],0.0043035254466875,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,36,1.11 [1.03-1.19],0.00448964488408223,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD300C,CMRF35-like molecule 6,Inverse variance weighted,36,1.1 [1.03-1.18],0.0050192411419541,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,36,1.12 [1.03-1.21],0.0051935001851604,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,36,1.08 [1.02-1.14],0.00529125223270331,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,36,1.1 [1.03-1.18],0.0052916740757369,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,36,1.08 [1.02-1.15],0.0056009135295834,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SIGLEC1,Sialoadhesin,Inverse variance weighted,36,1.08 [1.02-1.14],0.00603802816136369,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,36,1.09 [1.03-1.16],0.00610439606996589,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,36,1.09 [1.02-1.15],0.00624689826860398,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,36,1.09 [1.02-1.15],0.00630163600367493,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,36,1.1 [1.03-1.17],0.00643904123264409,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,FCRLB,Fc receptor-like B,Inverse variance weighted,36,1.08 [1.02-1.15],0.00709865927011771,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IL22,Interleukin-22,Inverse variance weighted,36,1.17 [1.04-1.31],0.00717576569985985,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,KLK4,Kallikrein-4,Inverse variance weighted,36,1.05 [1.01-1.1],0.00722476515973361,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,36,1.09 [1.02-1.16],0.00742951376955123,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,RNASET2,Ribonuclease T2,Inverse variance weighted,36,1.1 [1.02-1.17],0.00763658390302333,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD300A,CMRF35-like molecule 8,Inverse variance weighted,36,1.11 [1.03-1.2],0.00791936916828071,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,36,1.07 [1.02-1.13],0.00859243987567884,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LGALS9,Galectin-9,Inverse variance weighted,36,1.08 [1.02-1.15],0.00889260010631636,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,36,1.09 [1.02-1.15],0.00890374847215488,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,36,1.08 [1.02-1.14],0.0105200508066193,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,36,1.08 [1.02-1.14],0.0107026622614723,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,36,1.08 [1.02-1.14],0.0107667872975733,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD48,CD48 antigen,Inverse variance weighted,36,1.08 [1.02-1.14],0.0110798830595872,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,36,1.1 [1.02-1.18],0.0111386106363367,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,36,1.08 [1.02-1.14],0.0118688297686839,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,36,1.07 [1.01-1.13],0.0119891301313333,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,36,1.08 [1.02-1.15],0.0120862078285415,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,GRN,Progranulin,Inverse variance weighted,36,1.06 [1.01-1.11],0.0147265785734066,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,36,1.09 [1.02-1.17],0.0149050511784457,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,HGF,Hepatocyte growth factor,Inverse variance weighted,36,1.07 [1.01-1.13],0.0149266301286524,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,36,1.07 [1.01-1.12],0.0152323534547587,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,36,1.07 [1.01-1.14],0.0155354200352294,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,36,1.07 [1.01-1.14],0.0162513997131727,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PGF,Placenta growth factor,Inverse variance weighted,36,1.06 [1.01-1.12],0.0177949211690744,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,DLL1,Delta-like protein 1,Inverse variance weighted,36,1.08 [1.01-1.15],0.0183180220644556,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,36,1.09 [1.01-1.17],0.018572021057294,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,36,1.08 [1.01-1.14],0.0190054443685388,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,36,1.08 [1.01-1.15],0.0208509893915553,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,36,1.08 [1.01-1.14],0.0216356448559932,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,36,1.08 [1.01-1.16],0.0221209115875919,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,36,1.08 [1.01-1.16],0.0221288688956881,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,36,1.07 [1.01-1.13],0.0242649295826663,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,36,1.07 [1.01-1.14],0.0258866005513873,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,36,1.1 [1.01-1.21],0.0259278518477303,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,36,1.09 [1.01-1.17],0.0269718115441531,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,36,1.07 [1.01-1.14],0.0277059503786486,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CCL20,C-C motif chemokine 20,Inverse variance weighted,36,1.06 [1.01-1.11],0.0278434730704573,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SHISA5,Protein shisa-5,Inverse variance weighted,36,1.08 [1.01-1.16],0.0286528290455768,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,36,1.07 [1.01-1.13],0.0295820713326374,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,36,1.08 [1.01-1.15],0.0306617115140832,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,DPY30,Protein dpy-30 homolog,Inverse variance weighted,36,1.08 [1.01-1.16],0.0317402506450646,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,36,1.07 [1-1.13],0.0350948813891379,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,36,1.06 [1-1.11],0.0426512735229443,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LY96,Lymphocyte antigen 96,Inverse variance weighted,36,1.09 [1-1.19],0.0461472932370267,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,36,1.05 [1-1.11],0.0483457131886943,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ADA2,Adenosine deaminase 2,Inverse variance weighted,36,1.07 [1-1.15],0.0512504553930211,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,EFNA1,Ephrin-A1,Inverse variance weighted,36,1.06 [1-1.13],0.0528937063048479,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,1.1 [1-1.21],0.0535383594799044,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SPON1,Spondin-1,Inverse variance weighted,36,1.06 [1-1.12],0.0600730643808416,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD27,CD27 antigen,Inverse variance weighted,36,1.08 [1-1.17],0.0604856104090893,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,36,1.06 [1-1.13],0.0606152766888928,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CHRDL1,Chordin-like protein 1,Inverse variance weighted,36,1.05 [1-1.11],0.0636261797595716,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CCL21,C-C motif chemokine 21,Inverse variance weighted,36,1.06 [1-1.12],0.0656475676367393,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,36,1.07 [1-1.15],0.0659818761738868,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,36,1.06 [1-1.12],0.069729865354145,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,36,1.05 [1-1.12],0.0728066893142313,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,36,1.05 [0.99-1.12],0.0746347062590668,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,36,1.06 [0.99-1.13],0.0759893880922778,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,36,1.05 [0.99-1.11],0.0779126182607802,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,36,1.05 [0.99-1.11],0.0782971729879748,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,36,1.07 [0.99-1.15],0.0795062152304323,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ULBP2,UL16-binding protein 2,Inverse variance weighted,36,1.06 [0.99-1.13],0.0806608617407127,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,36,1.06 [0.99-1.14],0.0811160278068712,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CKB,Creatine kinase B-type,Inverse variance weighted,36,1.05 [0.99-1.12],0.0813051846900193,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,36,1.05 [0.99-1.1],0.081637468718991,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,36,1.07 [0.99-1.15],0.0821942745703244,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,36,1.05 [0.99-1.11],0.0845869718334924,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,36,1.04 [0.99-1.09],0.0930182039774665,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,36,1.05 [0.99-1.1],0.0932865637282832,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,REG1A,Lithostathine-1-alpha,Inverse variance weighted,36,1.05 [0.99-1.11],0.0943138868410364,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,36,1.05 [0.99-1.11],0.0970415830772365,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LMNB2,Lamin-B2,Inverse variance weighted,36,1.04 [0.99-1.1],0.102828351129213,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,36,1.05 [0.99-1.12],0.105316833528241,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,36,1.04 [0.99-1.1],0.112213750587713,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD276,CD276 antigen,Inverse variance weighted,36,1.04 [0.99-1.09],0.121372356468598,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,36,1.04 [0.99-1.1],0.125089162711383,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,36,1.04 [0.99-1.1],0.125856079635708,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,36,0.94 [0.87-1.02],0.128440372850434,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,36,1.05 [0.98-1.12],0.131741692512364,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TFF2,Trefoil factor 2,Inverse variance weighted,36,1.05 [0.99-1.11],0.13398112852594,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,FSTL3,Follistatin-related protein 3,Inverse variance weighted,36,1.05 [0.98-1.13],0.136884022274864,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CD302,CD302 antigen,Inverse variance weighted,36,1.04 [0.99-1.11],0.1439708736673,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,INHBB,Inhibin beta B chain,Inverse variance weighted,36,1.04 [0.99-1.1],0.144813182579932,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ANGPT2,Angiopoietin-2,Inverse variance weighted,36,1.04 [0.99-1.1],0.145930739706676,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,36,1.05 [0.98-1.12],0.17373677438511,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,36,1.04 [0.98-1.1],0.178000626298319,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CALCA,Calcitonin,Inverse variance weighted,36,1.03 [0.99-1.08],0.188655314761017,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SPP1,Osteopontin,Inverse variance weighted,36,1.03 [0.98-1.09],0.191115693775774,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LAYN,Layilin,Inverse variance weighted,36,1.05 [0.98-1.12],0.202475973791256,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,36,1.04 [0.98-1.1],0.207573163674746,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,36,1.04 [0.98-1.12],0.208602189151196,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,36,0.96 [0.9-1.02],0.214210884749546,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CCL15,C-C motif chemokine 15,Inverse variance weighted,36,1.03 [0.98-1.08],0.222052645686985,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,COLEC12,Collectin-12,Inverse variance weighted,36,1.04 [0.98-1.11],0.223321916693678,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,36,1.05 [0.97-1.14],0.226769536068634,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,36,1.03 [0.98-1.09],0.230618033823046,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,36,1.03 [0.98-1.09],0.233984014809941,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,GDF15,Growth/differentiation factor 15,Inverse variance weighted,36,1.03 [0.98-1.09],0.235946464142314,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,FSTL1,Follistatin-related protein 1,Inverse variance weighted,36,1.04 [0.97-1.1],0.24530962818917,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,36,1.04 [0.97-1.12],0.251064687422969,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,AREG,Amphiregulin,Inverse variance weighted,36,1.03 [0.98-1.08],0.25276160801287,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,36,1.04 [0.97-1.1],0.268239150618282,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,36,1.03 [0.97-1.1],0.299928938021033,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,REG1B,Lithostathine-1-beta,Inverse variance weighted,36,1.04 [0.97-1.11],0.303974283860559,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,36,1.03 [0.97-1.1],0.308446021598572,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,36,1.39 [0.73-2.67],0.317178116633273,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CTSL,Cathepsin L1,Inverse variance weighted,36,1.03 [0.97-1.09],0.365187053562904,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,36,1.03 [0.96-1.1],0.379351109668634,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,36,1.03 [0.97-1.09],0.397310696875387,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,36,1.03 [0.95-1.12],0.443897297302504,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,THBS2,Thrombospondin-2,Inverse variance weighted,36,1.02 [0.96-1.08],0.48228751992504,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,36,1.03 [0.96-1.1],0.485626269364656,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,FGF23,Fibroblast growth factor 23,Inverse variance weighted,36,0.97 [0.88-1.07],0.533684970421134,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,36,1.02 [0.96-1.08],0.554795438591588,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CA12,Carbonic anhydrase 12,Inverse variance weighted,36,0.98 [0.93-1.04],0.559556013111624,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,36,1.03 [0.93-1.13],0.604116163667033,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,NEFL,Neurofilament light polypeptide,Inverse variance weighted,36,1.01 [0.96-1.07],0.629022474380035,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,36,1.02 [0.92-1.14],0.688772109372078,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,36,0.97 [0.84-1.12],0.699154067298359,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PDCD1,Programmed cell death protein 1,Inverse variance weighted,36,0.97 [0.82-1.14],0.705570301537135,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CDH2,Cadherin-2,Inverse variance weighted,36,1.01 [0.96-1.06],0.742027569166288,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,CCN3,CCN family member 3,Inverse variance weighted,36,1.01 [0.95-1.07],0.776231991139554,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,PLXNB2,Plexin-B2,Inverse variance weighted,36,1.01 [0.96-1.05],0.808859236735003,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SPON2,Spondin-2,Inverse variance weighted,36,1 [0.94-1.06],0.898166111631347,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,36,1 [0.95-1.05],0.919691046396217,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,36,1 [0.83-1.22],0.961510529619002,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,36,1 [0.95-1.05],0.962639261292249,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,36,1 [0.94-1.06],0.970291632012344,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,SDC1,Syndecan-1,Inverse variance weighted,36,1 [0.95-1.05],0.989800463570859,trans
Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,EPO,Erythropoietin,Inverse variance weighted,36,1 [0.95-1.05],0.993095560799061,trans
